| 1. | | Recruiting | 12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
Conditions: chronic myeloproliferative disorders; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; plasma cell neoplasm |
| 2. | | Recruiting | 17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 3. | | Recruiting | 17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphomas
Conditions: adult solid tumor; Leukemia; Lymphoma |
| 4. | | Recruiting | 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer
Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome |
| 5. | | Recruiting | 17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease
Conditions: Hippel-Lindau Disease; Kidney Cancer |
| 6. | | Recruiting | 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors
Conditions: refractory plasma cell neoplasm; stage III multiple myeloma; unspecified adult solid tumor, protocol specific |
| 7. | | Recruiting | A 6-week safety & efficacy study of combination intraocular pressure-lowering therapy in patients with open-angle glaucoma or ocular hypertension
Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
| 8. | | Recruiting | A 6-week safety and efficacy study of Travatan compared to Xalcom in subjects with open-angle glaucoma(OAG) or ocular hypertension(OHT)
Conditions: Glaucoma, Open-Angle; Ocular Hypertension |
| 9. | | Recruiting | Abciximab (ReoPro) in Acute Ischemic Stroke
Condition: Stroke |
| 10. | | Recruiting | ACE Inhibition and Novel Cardiovascular Risk Factors
Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension |
| 11. | | Recruiting | Action to Control Cardiovascular Risk in Diabetes (ACCORD)
Conditions: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus; ... |
| 12. | | Recruiting | Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation
Conditions: Cancer; oral complications of cancer and cancer therapy; Pain |
| 13. | | Recruiting | Adjunctive Drug Treatment for Ischemic Stroke Patients
Condition: Cerebrovascular Accident |
| 14. | | Recruiting | Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma
Conditions: stage II multiple myeloma; stage III multiple myeloma |
| 15. | | Recruiting | African-American Heart Failure Trial
Condition: Congestive Heart Failure |
| 16. | | Recruiting | Air Pollution and Implantable Cardioverter Defibrillators
Condition: arrythmias |
| 17. | | Recruiting | Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
Condition: Waldenstrom's Macroglobulinemia |
| 18. | | Not yet recruiting | Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease; Non-Hodgkin's Lymphoma; ... |
| 19. | | Recruiting | Alemtuzumab, Total-Body Irradiation, and Fludarabine Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 20. | | Recruiting | Alfimeprase for thrombolysis in Acute Peripheral Arterial Occlusion
Conditions: Arterial Occlusive Diseases; Peripheral Vascular Diseases; Thrombosis |
| 21. | | Recruiting | Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
Condition: Fabry Disease |
| 22. | | Recruiting | Angiomax in Patients with HIT/HITTS Type II Undergoing CPB
Conditions: Cardiovascular Disease; Coronary Artery Bypass Surgery |
| 23. | | Recruiting | Angiomax in Patients with HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)
Conditions: Thrombocytopenia; Thrombosis; Cardiac Disease; Coronary Artery Bypass Surgery |
| 24. | | Recruiting | Angiotensin-II Blockade in Mitral Regurgitation
Conditions: Heart Diseases; Mitral Valve Insufficiency |
| 25. | | Recruiting | Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; Infection |
| 26. | | Recruiting | Anticoagulation, Vitamins, and Endothelial Function
Condition: Cardiovascular Diseases |
| 27. | | Recruiting | Antidepressant Medication Treatment for Depression in Individuals with Congestive Heart Failure
Conditions: Heart Failure, Congestive; Depression |
| 28. | | Recruiting | Antineoplaston Therapy in Treating Patients With Multiple Myeloma
Conditions: refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 29. | | Recruiting | Antiviral Therapy in Treating Patients With Slowly Progressing HIV-Related Kaposi's Sarcoma
Condition: epidemic Kaposi's sarcoma |
| 30. | | Recruiting | ARIES - Ambrisentan in Patients with Moderate to Severe Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Hypertension |
| 31. | | Recruiting | ARISE – Aggressive Reduction of Inflammation Stops Events
Conditions: Atherosclerosis; Coronary Artery Disease; Myocardial Infarction; Unstable Angina |
| 32. | | Recruiting | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Lymphoma or Leukemia
Conditions: adult non-Hodgkin's lymphoma; Chronic Lymphocytic Leukemia; indolent or aggressive adult non-Hodgkin's lymphoma; Prolymphocytic Leukemia; ... |
| 33. | | Recruiting | Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma
Condition: refractory plasma cell neoplasm |
| 34. | | Recruiting | Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions
Condition: Kaposi's Sarcoma |
| 35. | | Recruiting | Assessment of Patients with Multiple Sclerosis (MS)
Conditions: Herpesviridae Infection; HTLV-I Infection; Multiple Sclerosis; Tropical Spastic Paraparesis; Vasculitis |
| 36. | | Recruiting | Assisted Movement Neuro-Rehabilitation: VA Multi-Site Clinical Trials
Condition: Cerebrovascular Accident |
| 37. | | Not yet recruiting | Autologous Cultured Myoblasts (BioWhittaker) Transplanted via Myocardial Injection
Conditions: Congestive Heart Failure; Coronary Artery Disease; Myocardial Infarction |
| 38. | | Recruiting | Automated Constraint-Induced Therapy for Restoring Movement after Stroke
Condition: Cerebrovascular Accident |
| 39. | | Recruiting | Bendamustine in Treating Patients With Rituximab-Refractory Indolent B-Cell Non-Hodgkin’s Lymphoma
Conditions: adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma |
| 40. | | Recruiting | Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
Conditions: Cerebral Palsy; Intraventricular hemorrhage; Periventricular Leukomalacia; Pulmonary Edema; Abruptio Placentae |
| 41. | | Recruiting | Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients
Conditions: Kaposi's Sarcoma; HIV Infections; HIV Seronegativity |
| 42. | | Recruiting | Bevacizumab With or Without Thalidomide in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 43. | | Recruiting | Biological Markers in Retinal Vasculitis
Condition: Retinal Vasculitis |
| 44. | | Recruiting | Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation
Condition: refractory plasma cell neoplasm |
| 45. | | Recruiting | Bivalirudin in Patients with Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)
Condition: Myocardial Infarction |
| 46. | | Recruiting | Blood and Marrow Transplant Clinical Research Network
Conditions: Bone Marrow Transplantation; Blood Disease; Hematopoietic Stem Cell Transplantation; Leukemia; Multiple Myeloma; Myelodysplastic Syndromes; ... |
| 47. | | Recruiting | Blood Factors and Diabetic Retinopathy
Condition: Diabetic Retinopathy |
| 48. | | Recruiting | Body Cooling for Birth Asphyxia in Term Infants
Conditions: Hypoxic-Ischemic Encephalopathy; Asphyxia; Brain Ischemia; Hypoxia, Brain |
| 49. | | Recruiting | Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 50. | | Recruiting | Bone Marrow Transplantation in Treating Patients With Multiple Myeloma, Chronic Phase Chronic Myelogenous Leukemia, or Agnogenic Myeloid Metaplasia
Conditions: chronic idiopathic myelofibrosis; Chronic Myelogenous Leukemia; Multiple Myeloma; refractory plasma cell neoplasm |
